Vivek Sharma – CEO, Piramal Pharma Solutions (PPS)
Vivek Sharma, CEO of Piramal Pharma Solutions (PPS), one of the world’s leading CDMOs with a presence in North America, Europe, and Asia, provides insights into the main trends shaping…
Address: No. 28, Mehta Vora Chamber, Mahendra Mansion, Babu Genu RoadMumbai – 400 002, Maharashtra, India
Tel: 91 22 26101320
Web: http://www.apexdrugs.com/
Started in 1979 as an Importer for Bulk Drug and API’s, Today Apex Drug House has diversified into manufacturing of pharmaceutical formulations and is at the forefront in developing and marketing for International markets. Our products are manufactured in WHO GMP, NAFDAC, NDA and FDB certified facilities where various forms of pharmaceuticals like Tablets, Capsules, Syrups, Ointments, Lozenges, Dry Powder Injections, Liquid Injections, Ophthalmic solutions and Aerosols are manufactured. Additionally Apex also manufactures Herbals, Soft Gelatin Capsules, Lozenges and specialty products like Mosquito Repellents and Condoms. We focus on providing quality products and continually invest our time and resources in the quest to achieve higher levels of quality products and earned reputation from our clients.
Apex Drug House has a strong presence in regions like Latin America, South East Asia, CIS and African regions. With the know-how and the capacity of our plants we are close to our customers in important markets. We provide a worldwide supply chain, making sure that products will be available when and where they are needed. Our strong portfolio of products gives us an edge in an increasingly competitive global market and allows us to provide affordable medication to people across the world, regardless of geographic and socio-economic barriers.
Apex Drug House is a fully integrated pharmaceutical formulation company at the forefront in developing, manufacturing and marketing of formulations for International markets. Additionally Apex also manufactures Herbals, and specialty products like Mosquito Repellents and Condoms. Our strong portfolio of products gives us an edge in an increasingly competitive global market and allows us to provide affordable medication to people across the world.
Vivek Sharma, CEO of Piramal Pharma Solutions (PPS), one of the world’s leading CDMOs with a presence in North America, Europe, and Asia, provides insights into the main trends shaping…
Swati Jajodia, managing director of Swati Spentose discusses her commitment to tackling underserved diseases and the company’s approach to bringing pentosan polysulfate to global markets while working with Key Opinion…
Jai and Sameer Hiremath of Hikal provide insights into the main trends shaping the Indian and global CDMO industry. They articulate how Hikal’s long-standing focus on quality standards, regulatory compliance,…
Dr. Hemant Koshia, commissioner of the FDCA Gujarat, the regulatory authority of the state of Gujarat – India’s leading hub for the production of pharmaceutical and healthcare products – provides…
Dr. Georges Jabre, the recently appointed CEO of Serdia Pharmaceuticals (India) Pvt. Ltd. (an affiliate of the Servier Group) and president of the Healthcare Committee of the Indo-French Chamber of…
Bharat V. Daftary, chairman and MD of Bharat Serums & Vaccines (BSV), a biopharmaceutical company with R&D units in USA, Germany & India and with a presence in over 76…
Yugal Sikri, chairman of the Pharmaceutical Management Program of the prestigious NMIMS University, and with an extremely rich experience in the pharmaceutical industry, explains his mission to build a valuable…
Raghuveer Kini, executive director of the Pharmaceuticals Export Promotion Council of India (Pharmexcil) provides insights into the key success factors that have allowed India to become the world’s pharmaceutical hub…
Jean-Pierre Baylet, country head for India and cluster head for South Asia at Sanofi Pasteur, provides insights into the progress and room for improvement that lie ahead for India’s immunization…
Dr. Deepak Sawant, Minister of Public Health and Family Welfare in the Government of Maharashtra, provides insights into some crucial achievements with regards to the state’s infant and child mortality…
The global pharmaceutical outsourcing market was estimated to be USD 115.7 billion in 2016, of which 49 percent is accounted for by contract research organisations (CROs). Within India, the contract…
In this exclusive interview, Binish Chudgar, vice-chairman and managing director of Intas, the largest privately-owned Indian pharmaceutical company with sales of over USD 1.7 billion during the last financial year,…
See our Cookie Privacy Policy Here